Cardiovascular tissue engineering

04 September 2017

There is a persistent and growing clinical need for readily-available substitutes for heart valves and small-diameter blood vessels. In situ tissue engineering is emerging as a disruptive new technology, providing ready-to-use biodegradable, cell-free constructs which are designed to induce regeneration upon implantation, directly in the functional site. The induced regenerative process hinges around the host response to the implanted biomaterial and the interplay between immune cells, stem/progenitor cell and tissue cells in the microenvironment provided by the scaffold in the hemodynamic environment. Recapitulating the complex tissue microstructure and function of cardiovascular tissues is a highly challenging target. Therein the scaffold plays an instructive role, providing the microenvironment that attracts and harbors host cells, modulating the inflammatory response, and acting as a temporal roadmap for new tissue to be formed. Moreover, the biomechanical loads imposed by the hemodynamic environment play a pivotal role. Here, we provide a multidisciplinary view on in situ cardiovascular tissue engineering using synthetic scaffolds; starting from the state-of-the art, the principles of the biomaterial-driven host response and wound healing and the cellular players involved, toward the impact of the biomechanical, physical, and biochemical microenvironmental cues that are given by the scaffold design. To conclude, we pinpoint and further address the main current challenges for in situ cardiovascular regeneration, namely the achievement of tissue homeostasis, the development of predictive models for long-term performances of the implanted grafts, and the necessity for stratification for successful clinical translation.

The above text is the abstract from the open review article ‘Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective’. Licensed under CC BY 4.0. No adaptions are made on the abstract. Read more about the article.

Electrospun biomaterial-driven in situ cardiovascular tissue engineering

vascular tissue

Figure from: Biomaterial-driven in situ cardiovascular tissue engineering—a multi-disciplinary perspective

 

 

 

 

 

 

 

 

 

 

Overview of the different stages of in situ tissue regeneration, going from a synthetic, biodegradable bare construct toward a viable substitute (a). Although many aspects underlying in situ regeneration remain unknown, it is hypothesized that the stages mirror the natural phases of the wound healing response (b), starting with the inflammatory phase, characterized by the infiltration of immune cells and the formation of a preliminary matrix. The subsequent proliferative phase is characterized by a secondary influx of immune and tissue producing cells, extracellular matrix (ECM) deposition, angiogenesis and (re-)endothelialization of the construct. Tissue homeostasis is restored after a remodeling phase of the newly formed ECM and the resolution of inflammation. Photographs of heart valves adapted from;33 photographs of vascular grafts courtesy of Renée Duijvelshoff.

Publication: https://www.nature.com/articles/s41536-017-0023-2#Fig1
Authors: Tamar B. Wissing, Valentina Bonito, Carlijn V. C. Bouten & Anthal I. P. M. Smits
Article number: 18 (2017)
Doi:10.1038/s41536-017-0023-2
Published online: 16 June 2017
License: CC BY 4.0